Combination Treatment for Moderate to Severe Acne

• Status: Completed
• Trial end date: 2011-07-01
• Target enrollment: 0
• Participant gender: All

Summary

To determine if a combination of three currently approved acne products are safe and effective for the treatment of moderate to severe acne

• Phase: Phase 4
• Accepts Healthy Volunteers?: Accepts Healthy Volunteers

Details

• Lead Sponsor: Medicis Global Service Corporation
• Treatments: Benzoyl Peroxide; Clindamycin; Clindamycin palmitate; Clindamycin phosphate; Minocycline; Tretinoin

Criteria

Inclusion Criteria:

• moderate to severe acne, IGA = 3 or 4 (Investigator Global Assessment)

Exclusion Criteria:

• pregnancy and allergies